Table 3.
Diagnostic performance of the clinical factor model, the radiomics signature, and the radiomics nomogram.
Model | Group | AUC (95% CI) | Sensitivity | Specificity | Accuracy | PPV | NPV | F1-score |
---|---|---|---|---|---|---|---|---|
Clinical factor model | Training cohort | 0.803 (0.723–0.876) | 0.891 (98/110) | 0.633 (19/30) | 0.836 (117/140) | 0.899 (98/109) | 0.613 (19/31) | 0.895 |
Internal validation cohort | 0.763 (0.603–0.841) | 0.875 (42/48) | 0.571 (8/14) | 0.806 (50/62) | 0.875 (42/48) | 0.571 (8/14) | 0.875 | |
External validation cohort | 0.817 (0.690–0.833) | 0.533 (16/30) | 1 (13/13) | 0.674 (29/43) | 1 (16/16) | 0.481 (13/27) | 0.696 | |
Radiomics signature | Training cohort | 0.813 (0.743–0.877) | 0.736 (81/110) | 0.7 (21/30) | 0.729 (102/140) | 0.9 (81/90) | 0.42 (21/50) | 0.81 |
Internal validation cohort | 0.787 (0.606–0.825) | 0.667 (32/48) | 0.786 (11/14) | 0.694 (43/62) | 0.914 (32/35) | 0.407 (11/27) | 0.771 | |
External validation cohort | 0.718 (0.531–0.778) | 0.633 (19/30) | 0.692 (9/13) | 0.651 (28/43) | 0.826 (19/23) | 0.45 (9/20) | 0.717 | |
Radiomics nomogram | Training cohort | 0.887 (0.827–0.940) | 0.818 (90/110) | 0.8 (24/30) | 0.814 (114/140) | 0.938 (90/96) | 0.545 (24/44) | 0.874 |
Internal validation cohort | 0.885 (0.816–0.922) | 0.75 (36/48) | 1 (14/14) | 0.806 (50/62) | 1 (36/36) | 0.538 (14/26) | 0.857 | |
External validation cohort | 0.851 (0.720–0.919) | 0.8 (24/30) | 0.846 (11/13) | 0.814 (35/43) | 0.923 (24/26) | 0.647 (11/17) | 0.857 |
PPV, positive predictive value; NPV, negative predictive value.